Fermion-Header

Fermion-Header

X

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

All Data

Filters

×

FILTER:

filter

News Type

filter

Company

filter

Product Type

filter

Deal Size

filter

Upfront Payment

Active Filter(s):

Reset Filter

All Drugs in Dev.

Product Type

Companies

Molteni Farmaceutici

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

SupplySide West 2021

Participation Not Confirmed

Update your Virtual Booth

Titan Pharma Completes Debt Settlement with Molteni and Horizon; Acquisition of JT-09

Lead Product(s): JT-09

Therapeutic Area: Dermatology Product Name: JT-09

Highest Development Status: Preclinical Product Type: Peptide

Partner/Sponsor/Collaborator: Titan Pharmaceuticals Inc

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Public Offering November 02, 2020

Details:

As a result of the debt settlement with Molteni and Horizon, there are no liens remaining on any of